Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Narjust Florez, M.D.

Concepts (259)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Narjust Florez's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Narjust Florez has written about over time.
Immunotherapy, 8 publications between 2018 and 2024, average publication date February 2021. Minority Groups, 9 publications between 2017 and 2024, average publication date November 2021. Neoplasms, 29 publications between 2017 and 2024, average publication date November 2021. Physicians, Women, 3 publications between 2021 and 2023, average publication date April 2022. Medical Oncology, 16 publications between 2017 and 2024, average publication date May 2022. Physicians, 6 publications between 2021 and 2024, average publication date May 2022. Carcinoma, Non-Small-Cell Lung, 16 publications between 2019 and 2024, average publication date June 2022. Lung Neoplasms, 25 publications between 2015 and 2024, average publication date July 2022. Sexual Dysfunction, Physiological, 3 publications between 2020 and 2023, average publication date October 2022. Hematology, 3 publications between 2021 and 2023, average publication date December 2022. Weather, 1 publications between 2023 and 2023, average publication date August 2023. Vaginal Diseases, 1 publications between 2023 and 2023, average publication date October 2023. Medical Tourism, 1 publications between 2023 and 2023, average publication date October 2023.

To see the data from this visualization as text, click here.
Florez's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (259)
Explore
_
Co-Authors (35)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.